Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers
US8933132B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2012 |
| Grant date | Jan 13, 2015 |
| Priority date | — |
| Expiry date | Jan 19, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel piperazine compounds of formula (I):to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial, i.e. in particular to treat pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.